
Healthcare · NSE
Pramodini Medicare Limited, incorporated in 2000, is a technology-enabled diagnostic healthcare company providing radiology, clinical laboratory, and nuclear medicine services across India. The company offers a wide range of diagnostic solutions, including MRI, CT scans, X-rays, ultrasound, mammography, pathology, microbiology, biochemistry, PET-CT, SPECT, and nuclear medicine services. It serves government and private hospitals, public sector undertakings (PSUs), medical colleges, and standalone diagnostic centres through multiple partnership models. With a network of diagnostic centres, a 24×7 teleradiology facility, and advanced healthcare technology, Pramodini Medicare focuses on delivering accurate, reliable, and accessible diagnostic services across Tier I, II, and III cities.
Price Band
₹110 – ₹118
Issue Size
₹585.12 L Cr
Lot Size
1200 shares
GMP
Est. Listing
₹118
at current GMP
Subscribed
3.96x
overall
Open
12 Aug 2026
Close
14 Aug 2026
Allotment
17 Aug 2026
Refund
18 Aug 2026
Demat Credit
19 Aug 2026
Listing
19 Aug 2026
Overall Subscription
3.96x
Total Demand
QIB Multiplier
3.66x
Institutions & Funds
NII / HNI
5.31x
High Net-Worth
Retail (RII)
3.49x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 1,171,200 | 4,282,800 | 3.66x |
| NIB | 960,000 | 5,095,200 | 5.31x |
| HNIs(10L +) | 639,600 | 3,552,000 | 5.55x |
| HNIs (2-10L) | 320,400 | 1,543,200 | 4.82x |
| RETAIL | 2,023,200 | 7,053,600 | 3.49x |
| Total | 5,114,400 | 21,526,800 | 3.96x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 13 | 0.00x |
| NIB | — | 737 | 0.00x |
| RETAIL | 843 | 2,939 | 3.49x |
| HNIs(10L +) | 178 | 325 | 1.83x |
| HNIs (2-10L) | 89 | 412 | 4.63x |
| Total Applications | 1,110 | 4,426 | 3.99x |
Pramodini Medicare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹58,51,200 Crores. The shares are offered at a price band of ₹110 to ₹118 per equity share on NSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,41,600 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Purva Sharegistry India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2026-08-19, while un-allotted funds or UPI block mandates will be released on 2026-08-18.
The Pramodini Medicare Limited IPO aggregate issue size is ₹58,51,200 Crores with an equity price band set at ₹110 to ₹118 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,41,600.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. You can track QIB, NII/HNI, and Retail category multiples directly on our dedicated live subscription page.
The basis of allotment will be published on the official registrar portal (Purva Sharegistry India Private Limited) and the BSE status verification website on or around 2026-08-17.